Clinical markers of long-term disability in RRMS patients treated with interferon beta

被引：0
|
作者：
Rio, J. [1 ]
Otero-Romero, S. [1 ,2 ]
Tintore, M. [1 ]
Comabella, M. [1 ]
Nos, C. [1 ]
Negrotto, L. [1 ]
Galan, I. [1 ]
Vidal-Jordana, A. [1 ]
Castillo, J. [1 ]
Palavra, F. [1 ]
Simon, E. [1 ]
Arrambide, G. [1 ]
Sastre-Garriga, J. [1 ]
Montalban, X. [1 ]
机构：
[1] Vall Hebron Univ Hosp, Multiple Sclerosis Ctr Catalonia, Dept Neuroimmunol, Barcelona, Spain
[2] Vall Hebron Univ Hosp, Prevent Med & Epidemiol Dept, Barcelona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P285
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [1] Markers of long-term disability in RRMS patients treated with interferon beta
    Rio, J.
    Rovira, A.
    Tintore, M.
    Otero-Romero, S.
    Comabella, M.
    Vidal-Jordana, A.
    Galan, I.
    Castillo, J.
    Arrambide, G.
    Nos, C.
    Auger, C.
    Sastre-Garriga, J.
    Montalban, X.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 639 - 639
  • [2] Interferon Beta and Long-term Disability in Multiple Sclerosis
    Shirani, Afsaneh
    Zhao, Yinshan
    Karim, Mohammad Ehsanul
    Evans, Charity
    Kingwell, Elaine
    van der Kop, Mia L.
    Oger, Joel
    Gustafson, Paul
    Petkau, John
    Tremlett, Helen
    JAMA NEUROLOGY, 2013, 70 (05) : 651 - 652
  • [3] Long-term adherence to interferon-beta treatment in a cohort of RRMS patients in Belgrade, Serbia
    Mesaros, S.
    Stojsavljevic, N.
    Dujmovic-Basuroski, I.
    Dejanovic, I.
    Pekmezovic, T.
    Drulovic, J.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (08) : 1145 - 1148
  • [4] Interferon Beta and Long-term Disability in Multiple Sclerosis reply
    Greenberg, Benjamin M.
    Frohman, Elliot
    JAMA NEUROLOGY, 2013, 70 (05) : 652 - 653
  • [5] Predictors of Long-Term Outcome in Multiple Sclerosis Patients Treated with Interferon Beta
    Bermel, Robert A.
    You, Xiaojun
    Foulds, Pamela
    Hyde, Robert
    Simon, Jack H.
    Fisher, Elizabeth
    Rudick, Richard A.
    ANNALS OF NEUROLOGY, 2013, 73 (01) : 95 - 103
  • [6] Long-term emotional state of multiple sclerosis patients treated with interferon beta
    Porcel, J.
    Rio, J.
    Sánchez-Betancourt, A.
    Arevalo, M. J.
    Tintore, M.
    Tellez, N.
    Borras, C.
    Nos, C.
    Montalban, X.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (06) : 802 - 807
  • [7] Long-term lymphocyte counts in patients with RRMS treated with cladribine tablets
    Soelberg-Sorensen, Per
    Dangond, Fernando
    Hicking, Christine
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP4 - NP4
  • [8] Observational, retrospective study to characterise patients with RRMS and long-term treatment with sc interferon (IFN) beta 1-a
    Ara, J. R.
    Martinez-Yelamos, S.
    Saiz, A.
    Escartin, A.
    Munteis, E.
    Hernandez, M. A.
    Midaglia, L.
    Arias, M.
    Aladro, Y.
    de Andres, C.
    Garcia Merino, J. A.
    Olascoaga, X.
    Casanova, B.
    Roque, A.
    Brieva, L.
    Rodriguez-Antiguedad, A.
    Munoz, D.
    Fernandez, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 665 - 665
  • [9] Long-Term Lymphocyte Counts in Patients with RRMS Treated with Cladribine Tablets (CT)
    Soelberg-Sorensen, P.
    Dangond, F.
    Hicking, C.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 397 - 397
  • [10] Analysis of 6-month Confirmed Disability Progression in RRMS Patients Treated with Subcutaneous Interferon beta-1a
    Wong, Schiffon
    Aldridge, Julie
    Hettle, Robert
    Khurana, Inderpreet Singh
    Siddiqui, Mohd Kashif
    NEUROLOGY, 2018, 90
12345